Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-053487

CBO & EVP sold 39,878 shares at $32.78 ($1,307,201)

  • CBO & EVP acquired 39,878 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kassberg Thomas Richard · CBO & EVP

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-10-23 Exercise or conversion : show line 1 in the form 10b5-1 +39,878 $6.86 $273,563 286,738 D
2023-10-23 Sale : show line 2 in the form 10b5-1 −39,878 $32.78 $1,307,201 246,860 D
Open-market sales · 39,878 sh · avg $32.78 · $1,307,201

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-23 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −39,878 0 D
Loading xslF345X05/doc4.xml…